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ABSTRACT
The presence of a novel functional estrogen receptor on the human
sperm surface has been demonstrated by using different experimental
approaches. Ligand blot analysis of sperm lysates, using peroxidase-
conjugated estradiol as probe, identified a specific estradiol-binding
protein of approximately 29-kDa apparent molecular mass. The same
protein band was also revealed by using aH222 antibody, which is
directed against the steroid binding domain of the genomic estrogen
receptor. The biological effects of estrogen receptor were investigated
by analyzing calcium fluxes, tyrosine phosphorylation, and acrosome
reaction (AR) in response to 17b-estradiol (17bE2) and by measuring
the steroid influence on calcium and AR in responses to progesterone
(P), a well-known physiological stimulus for human spermatozoa. Our
results demonstrate that 17bE2 induces a rapid and sustained in-
crease of intracellular calcium concentrations ([Ca21]i). This effect is
totally dependent on the presence of extracellular calcium, because it
is completely abolished in a calcium-depleted medium. The dose-
response curve for calcium increase to 17bE2 is biphasic with a first
component in the nanomolar range (effective concentration 50 5
0.60 6 0.12 nmol/L) and a second component in the micromolar range
(EC50 5 3.80 6 0.26 mmol/L). 17bE2 stimulates tyrosine phosphory-
lation of several sperm proteins, including the 29-kDa protein band,
and determines a reduction of calcium response to P, finally resulting
in inhibition of P-stimulated sperm AR. Conversely, no direct effect
of 17bE2 is observed on AR. 17bE2 effects on calcium are clearly
mediated by a membrane receptor, because they are reproduced by
the membrane-impermeable conjugate of the hormone BSA-E2 and
reduced by sperm preincubation with aH222 antibody. Taken to-
gether, our results clearly show the presence of a functional surface
estrogen receptor, of 29 kDa, on human spermatozoa. This receptor
may play a role in the modulation of nongenomic action of P in these
cells during the process of fertilization. (J Clin Endocrinol Metab 84:
1670–1678, 1999)
SEVERAL steroid hormones have been demonstrated toexert rapid effects on cells by interacting with specific
receptors present on surface (1). In particular, estrogen has
been described as affecting intracellular calcium concentra-
tions ([Ca21]i), cAMP levels, mitogen-activated protein ki-
nase activity (2), phospholipase C (3) and A2 (4), and protein
kinase C (5) in different tissues and cell lines. Both proges-
terone (P) and estrogen are present at high levels in follicular
fluid (6–8). In particular, average estradiol concentrations in
follicular fluid from mature oocyte are in the micromolar
range (6–8). Rapid effects of both estradiol and P have been
extensively demonstrated in human oocytes, as well as their
role in oocyte activation and development (for review, see
Ref. 9). Although nongenomic effects of P on human sper-
matozoa have been well elucidated, showing that P stimu-
lates a cascade of signaling pathways leading to induction of
acrosome reaction (AR) (10) and functional P surface receptor
have been recently characterized (11), little is known about
the estrogen effects in these cells (for review, see Ref. 9). The
influence exerted by the steroid depletion in estrogen recep-
tor knock-out mice has been investigated recently on mat-
uration of spermatozoa (12), showing reduced motility and
absence of fertilizing potential. Moreover, several competi-
tive binding (13, 14) and immunofluorescence (15) studies
suggest the presence of specific binding sites for 17b-estra-
diol (17bE2) on human sperm surface. However, although
Cheng et al. (16) could not detect specific binding sites for
17bE2 in the sperm cytosolic and nuclear fractions, the effects
exerted by this steroid on sperm motility and fertilization
potential seem to be inhibited by the classical genomic re-
ceptor antagonist tamoxifen (17). Thus, at present, the nature
of these receptors remains unclear.
Interestingly, some interactions between P and estrogen at
membrane level have been suggested both in spermatozoa
and brain tissues. P competes with [3H]17bE2 binding to
intact human spermatozoa (18), and estradiol can displace
iodide P binding to a protein of 29 kDa identified on mouse
brain membrane lysates (19, 20).
In the present study, we report identification and partial
characterization of a novel receptor for estrogen on human
sperm membrane, using functional and biochemical ap-
proaches similar to those applied by our group to charac-
terize the nongenomic receptor for P on human sperm sur-
face (11). We investigated the biological effects of 17bE2 on
intracellular calcium levels in fura-2-loaded spermatozoa
and on AR. In addition, we examined the possible interfer-
ence exerted by this steroid on calcium and AR in response
to P. Finally, by ligand and Western blot analysis of sperm
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lysates, we initiated the molecular characterization of estro-
gen receptor and investigated the modulation of tyrosine
phosphorylation pattern of this protein in response to
administration of the steroid.
Materials and Methods
Chemicals
Percoll was obtained from Pharmacia LKB (Uppsala, Sweden). Hu-
man serum albumin-free human tubal fluid (HTF) was from Irvine
(Santa Ana, CA). All free steroids, peroxidase-conjugated estradiol (E2-
POD), 6-(O-carboxymethyl)oxime-estradiol conjugated with BSA (BSA-
E2), secondary conjugated antibodies, fluorescein isothiocyanate-labeled
Arachis hypogea (peanut) lectin, and all the other chemicals were from
Sigma Chemical Co. (St. Louis, MO). Reagents for SDS-PAGE and for
protein measurement were from Bio-Rad Laboratories, Inc. (Hercules,
CA). Monoclonal aH222 antibody was a kind gift of Prof. Geoffrey
Greene (The Ben May Institute for Cancer Research, University of Chi-
cago, Chicago, IL). Peroxidase-conjugated monoclonal (PY20-HRP) an-
tiphosphotyrosine antibodies were from ICN (Costa Mesa, CA). Digi-
tonin and Fura-2/AM were obtained from Calbiochem (La Jolla, CA).
The BM enhanced-chemiluminescence system was from Boehringer
(Mannheim, Germany).
Preparation of spermatozoa
Human semen was collected, according to the World Health Orga-
nization (WHO)-recommended procedure (21) by masturbation, from
normozoospermic men undergoing semen analysis for couple infertility.
Samples with a linear progressive motility of less than 50% and with
leukocytes and/or immature germ cell concentration greater than
106/mL were not included in the study. Semen samples were processed
as previously described (22). Briefly, spermatozoa were separated on 40
and 80% Percoll gradients, combined, washed in HTF medium contain-
ing 0.3% fatty acid free-BSA, and resuspended in the same medium at
the indicated concentration. Alternatively, sperms were separated by
swim-up collection, according to the WHO-recommended procedure
(21). Spermatozoa were capacitated for 2 h or otherwise indicated in 0.3%
BSA-containing HTF and treated as indicated in each experiment.
Preparation of sperm membranes
Sperm membranes were prepared as previously described (11).
Briefly, spermatozoa were lysed in lysis buffer [20 mmol/L Tris (pH 7.4),
150 mmol/L NaCl, 0.25% Nonidet P40, 1 mmol/L Na3VO4, 1 mmol/L
phenylmethanesulfonyl flouride] for 1 h on ice. Then the samples were
subjected to two subsequent cycles of homogenizing (teflon-glass) and
sonicating 3 3 15-sec 8 burst. The homogenates were centrifuged at 1,500
rpm for 10 min at 4 C, and supernatants were ultracentrifuged at 48,000
rpm for 45 min at 4 C. The resulting pellets (cellular membranes) were
resuspended in lysis buffer and homogenized.
Preparation of uterine and myometrial cell lysates
Human uterine samples in the proliferative phase of the menstrual
cycles, obtained at surgery, were processed as previously described (23).
Myometrial cells, obtained as previously described (23), were resus-
pended in lysis buffer (see above). After protein measurement (Biorad
kit, Bio-Rad Laboratories, Inc.), aliquots of cell extracts were applied
onto SDS-polyacrylamide gels.
Measurement of intracellular calcium concentration
Spermatozoa, prepared as described above, were loaded with 2
mmol/L Fura-2/AM for 45 min at 37 C, washed, resuspended in FM
medium (125 mmol/L NaCl, 10 mmol/L KCl, 2.5 mmol/L CaCl2, 0.25
mmol/L MgCl2, 19 mmol/L Na-lactate, 2.5 mmol/L Na-pyruvate, 2
mmol/L HEPES, 0.3% BSA, pH 7.5), and [Ca21]i, before and after stim-
ulation with the different agonists, was measured (as described previ-
ously) using a spectrofluorimetric method (22), except that, in the
present experiments, we used a Perkin-Elmer Corp. (Foster City, CA)
LS50B instrument equipped with a fast rotary filter shuttle for alternate
340- and 380-nm excitation. Fluorescence measurements were converted
to [Ca21]i by determining maximal fluorescence with 0.01% digitonin,
followed by minimal fluorescence with 10 mmol/L EGTA, pH 10.
[Ca21]i was calculated according to Grynkiewicz (24) using the ratio
340/380 and assuming a dissociation constant (Kd), of Fura-2 for cal-
cium, of 224 nmol/L.
SDS-PAGE
After the different incubations, as indicated, samples were processed
for SDS-PAGE as previously described (25). Briefly, sperm samples
containing 107 cells/mL were added with 1 mmol/L Na3VO4, centri-
fuged at 400 3 g at 4 C for 10 min, washed in PBS, and resuspended in
20 mL lysis buffer. After protein measurement (Biorad kit, Bio-Rad
Laboratories, Inc.), the sperm extracts, containing the same protein
amount, were diluted in an equal volume of reducing 23 loading buffer
(13 5 62.5 mmol/L Tris (pH 6.8), 10% glycerol, 20% SDS, 2.5% pyronin,
and 100 mmol/L dithiotheitrol), incubated at 95 C for 5 min, and loaded
onto 10% polyacrylamide-bisacrylamide midi- and minigels. After SDS-
PAGE, proteins were transferred to nitrocellulose membranes.
Ligand blot analysis
Nitrocelluloses filters with transferred proteins were treated for li-
gand blot analysis of sperm proteins, as previously described (11), with
slight modification. Briefly, the membranes were incubated for 30 min
in 3% NP-40/PBS, then for 2 h in 0.3% BSA/0.1% Tween-20/PBS for 10
min in 0.1% Tween-20/PBS, and overnight in 0.3% BSA/0.1% Tween-
20/PBS containing peroxidase-conjugated estradiol (E2-POD, 0.5 mmol/
L). After several washes in 0.1% Tween-20/PBS, reacted proteins were
revealed by a BM chemiluminescence system.
Western blot analysis
Nitrocelluloses filters with transferred proteins were blocked over-
night at 4 C in TTBS (0.1% Tween-20, 20 mmol/L Tris, 150 mmol/L
NaCl) containing 5% BSA, then washed repeatedly in TTBS, and incu-
bated for 2 h in 2% BSA-TTBS containing PY20-HRP antibody (1:1000).
After several washes in TTBS, reacted proteins were revealed by a BM
chemiluminescence system. In some experiments, blots were washed for
30 min at 50 C in stripping buffer (10 mmol/L Tris (pH 6.8), 1% SDS, 5
mmol/L b-mercaptoethanol), to remove bound antiphosphotyrosine
antibodies, then immunostaining was performed by 3-h incubation with
aH222 antibody (1:400 in 2% BSA-TTBS), followed by 1-h incubation
with antirat IgG-POD (1:4800 in 2% BSA-TTBS). Finally, the bands were
visualized by the BM system. The immunospecificity of PY20 was de-
termined by preadsorbing the antibody with 40 mmol/L o-phospho-
dl-tyrosine for 1 h at room temperature.
AR assay
Acrosome-reacted spermatozoa were evaluated using the fluorescent
probe fluorescein isothiocyanate-labeled Arachis hypogea (peanut) lec-
tin, according to Aitken et al. (26), as previously described (27). Briefly,
after 2-h capacitation, spermatozoa (106/mL) were preincubated for 10
min with 17bE2 at different concentrations and then stimulated with P
(10 mmol/L), or appropriate control solvent (dimethyl sulfoxide) for 2 h
at 37 C. After staining with fluorescent lectin, fluorescence was observed
under a fluorescent microscope (Leitz, Type 307–148.002, Wetzlar, Ger-
many), and AR was evaluated on a total of 100 spermatozoa/slide.
According to Aitken et al. (26), only curly-tailed spermatozoa were
considered viable and thus scored.
Analysis of experimental results
The computer program ALLFIT (28) was used for the analysis of
sigmoidal dose-response curves obtained in calcium studies. Data are
expressed as mean 6 sem. Statistical analysis was made with Student’s
t test and one-way ANOVA.
NONGENOMIC ESTROGEN RECEPTOR ON SURFACE 1671
Results
Effects of estradiol on intracellular calcium concentrations
in human spermatozoa
Addition of 17bE2 to fura-loaded spermatozoa induced
a rapid and sustained rise of [Ca21]i in a dose-dependent
manner. Figure 1 reports the typical calcium waves in
response to increasing concentrations of 17bE2 (0.1 nmol/
L–100 mmol/L). The dose-response curve for the calcium
effect of 17bE2, as generated by the simultaneous com-
puter analysis with the program ALLFIT (28), is biphasic
(Fig. 2), showing a first component with an effective con-
centration 50 of 0.60 6 0.12 nmol/L and a second com-
ponent with an EC50 of 3.80 6 0.26 mmol/L. Also, because
P stimulates a rapid calcium influx in human spermatozoa
with a similar biphasic dose-response curve (11), and in-
teractions between P and estrogen have been reported (19,
20), we tested the hypothesis of an eventual interference
between the effects of the two steroids. Interestingly, the
shapes of P- and 17bE2-induced calcium waves were dif-
ferent: P induced first a rapid peak, followed by a long
sustained plateau, whereas 17bE2 induced a slow sus-
tained response (Fig. 1). The typical [Ca21]i transient in
response to P (10 mmol/L) was reduced in a dose-depen-
dent manner by a previous administration of 17bE2, both
in the peak and plateau components (Fig. 1, also see Table
1). Table 1 reports the percentage peak and plateau [Ca21]i
increases in response to P (10 mmol/L) alone or after
previous administration of increasing concentrations of
17bE2. Inhibition of the plateau phase was statistically
significant for all the tested doses of estradiol, whereas
peak inhibition was statistically significant only for high
concentrations (Table 1). The effect of 17bE2 was specific
for P-response, because the steroid did not affect [Ca21]i
increase obtained after stimulation with the endoplasmic
Ca21-ATPase inhibitor thapsigargin (10 mmol/L, Fig. 3),
previously shown to increase calcium levels (29, 30) and
AR (31) in human spermatozoa. Effects of 17bE2, both on
calcium levels and on calcium response to P, were not
antagonized by the cytosolic estrogen receptor antagonist
tamoxifen (not shown), suggesting that the classical es-
trogen receptors are not involved. The effect of 17bE2
seemed to be specific, because comparable concentrations
of 17a-estradiol (17aE2), even at 10 mmol/L concentration,
neither stimulated [Ca21]i rise nor interfered with P-in-
duced response (Fig. 4). To further demonstrate that the
effect of 17bE2 on [Ca
21]i was mediated by a receptor
present on sperm membrane, we used the membrane-
impermeable estradiol conjugate BSA-E2. This compound
induced an [Ca21]i increase similar to that of 17bE2 (Fig.
5), whereas the addition of BSA alone, the macromolecular
component of the conjugate, was ineffective (not shown).
BSA-E2 was also able to mimic the inhibitory effect exerted
by the free steroid on P-induced calcium waves (Fig. 5).
The biological effects of BSA-E2 were observed until 0.1
mmol/L concentration was achieved, which elicited an
increase of basal [Ca21]i of about 1.16-fold (data not
shown). Taken together, all these data demonstrate that
17bE2 acts through interaction with a surface receptor. The
increase in [Ca21]i after addition of 17bE2 was totally de-
pendent on the presence of extracellular calcium, because
the response was absent when spermatozoa was stimu-
lated in calcium-depleted medium in the presence of 2
mmol/L EGTA, and it was restored by subsequent re-
placement of external calcium to normal levels (Fig. 6B).
Similarly, the calcium wave induced by BSA-E2 (1
mmol/L) was blunted in the absence of extracellular cal-
cium and was restored when [Ca21]e was replaced (Fig.
6C).
FIG. 1. Effects of increasing concentrations of 17bE2 on basal and
P-stimulated [Ca21]i in fura-2-loaded spermatozoa. Representative
calcium waves, in response to P (10 mmol/L) in control conditions (A)
and after a previous challenge with 100 mmol/L (B), 10 mmol/L (C), 10
nmol/L (D), and 0.1 nmol/L (E) 17bE2 are shown. Note that 17bE2
stimulates a dose-dependent increase of [Ca21]i. All tracings were
obtained in the same subject.
FIG. 2. Dose-response curve of the effect of 17bE2 on [Ca
21]i in fura-
2-loaded human spermatozoa. The percentage of the [Ca21]i increase
is reported on the ordinate and concentration of 17bE2 on the abscissa.
Each point represents the mean 6 SEM of percentage stimulation for
the number of the indicated experiments. The curve is generated by
the computer program ALLFIT (28) after simultaneous analysis of the
different dose-response curves. EC50 values of 17bE2 for the two
components of the curve are reported in the inset.
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Effects of estradiol on AR
Because a [Ca21]i rise, induced by P, leads to an increase
in AR of human spermatozoa, we next investigated whether
17bE2 effects on calcium were also involved in regulation of
AR. As shown in Fig. 7, 2-h incubation of capacitated
spermatozoa with increasing concentrations of 17bE2 in-
duced only a slight stimulation of AR at the highest dose
used (10 mmol/L). Interestingly, all the three doses of
17bE2 blunted AR in response to P (Fig. 7).
Identification of estradiol receptor by ligand and Western
blot analysis of human sperm lysates
To characterize 17bE2-binding proteins in human sperma-
tozoa, we performed, on total sperm lysates, ligand blot
experiments using E2-POD as probe, and Western analysis
with the monoclonal antibody aH222, directed against the
steroid-binding domain of the genomic receptor (32). E2-
POD has been shown to bind to a membrane estrogen re-
ceptor in pancreatic islet cells (33), indicating that such mol-
ecule is a good tool to investigate this type of receptor. aH222
antibody has been shown to recognize a membrane estrogen
receptor in rat pituitary tumor cells (34). Moreover, the ap-
proach of using an antibody produced against the steroid
binding sequence of the genomic receptor was applied by our
(11) and other groups (35, 36) to identify the putative mem-
brane receptors for P in human spermatozoa. In addition,
preincubation of sperm samples with aH222 antibody (1:20,
Fig. 8B), but not with normal rat serum (1:20, Fig. 8C), re-
duced 17bE2 stimulation of calcium influx (Fig. 8A), sug-
gesting that the sperm membrane receptor for estradiol is
recognized by this antibody. A single band, of approximately
29-kDa molecular mass, is revealed both by E2-POD (0.5
mmol/L, Fig. 9A) and aH222 antibody (1:400, Fig. 9B). An
estrogen-binding protein of similar molecular mass has been
described also in other cell types (19, 20, 37). The same pro-
FIG. 3. Effects of 17bE2 on calcium response to thapsigargin. Sperm
[Ca21]i increases, in response to thapsigargin (10 mmol/L) under con-
trol conditions (A) or after a previous challenge with 10 mmol/L 17bE2
(B), are shown. Results are representative of two similar experiments.
FIG. 4. Effects of 17aE2 on basal sperm [Ca
21]i and on calcium re-
sponse to P. Intracellular calcium waves, in response to P (10 mmol/L)
alone (A) and after a previous challenge with 10 mmol/L 17aE2 (B) or
17bE2 (C), are shown. Note that 17aE2 does not affect either basal or
P-stimulated [Ca21]i. Results are representative of three similar ex-
periments.
FIG. 5. Effects of the impermeable conjugate compound BSA-E2 on
basal [Ca21]i and on response to P. BSA-E2 (A) (10 mmol/L) stimulates
an increase of [Ca21]i and reduces calcium response to P (10 mmol/L),
similar to 17bE2 (B). Control response to P (10 mmol/L) in the same
subject is shown in C. Results are representative of four similar
experiments.
TABLE 1. Effects of different doses of 17bE2 on percentage peak and plateau [Ca





Stat PLATEAU% [Ca21]i increase
Stat
0 193.95 6 17.75 103.23 6 6.70
(n 5 42) (n 5 41)
1 mM 143.39 6 22.16 n.s. 49.52 6 6.06 P , 0.001
(n 5 16) 26% (n 5 15) 52%
100 mM 123.67 6 19.10 P , 0.02 35.92 6 4.10 P , 0.001
(n 5 17) 36% (n 5 16) 65%
10 mM 79.88 6 7.91 P , 0.001 14.60 6 1.54 P , 0.001
(n 5 26) 59% (n 5 24) 86%
Data represents the mean 6 SEM percentage stimulation for the number of experiments indicated in parenthesis. Statistical significance (stat)
of each point is calculated vs. respectively peak and plateau values in response to P in the absence of 17bE2 (0). Percentage of inhibition for
each 17bE2 concentration is also reported. n.s., Not significant.
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tein band of 29 kDa was detected on purified sperm mem-
branes stained with aH222 antibody (Fig. 9D). Longer ex-
posures of the aH222-stained blots revealed the presence of
two additional bands, of about 42–45 kDa and 54–58 kDa
(Fig. 9E). A protein band, at the expected 54–58 kDa molec-
ular mass range, probably corresponding to one of the
known isoforms of the genomic estrogen receptor (38, 39),
was detected by aH222 both on myometrial cell and total
uterus lysates, used as control for genomic estrogen receptors
(Fig. 10). Interestingly, myometrial cells also show the pres-
ence of a 29-kDa protein band (Fig. 10).
Because phosphorylation of estrogen genomic receptor
has been described as one of the mechanisms of receptor
transactivation (40, 41), we investigated whether p29 was
phosphorylated in tyrosine in human spermatozoa. Reprob-
ing the blots shown in Fig. 9, A and B, with PY20 antibody
revealed that this protein was phosphorylated on tyrosine
residues (Fig. 9C). Moreover, a rapid (10 min) stimulation of
capacitated spermatozoa with 17bE2 induced an increase of
phosphorylation in tyrosine residues of several protein
bands, including the p29 kDa one (Fig. 11A). A comigration
between this tyrosine phosphorylated band (Fig. 11A) and
the putative estrogen receptor was observed when the blot
was washed thoroughly and reprobed with aH222 antibody
(Fig. 11B).
Discussion
Our paper demonstrates the presence of a functional es-
trogen receptor on human sperm surface. This receptor ap-
parently is involved in the activation of two different signal
transduction pathways, namely an increase of [Ca21]i and of
tyrosine phosphorylation of proteins, resulting in inhibition
of P-stimulated calcium influx and AR. Ligand and Western
analyses of sperm lysates, using E2-POD and aH222 antibody
as probes, reveal the presence of a protein band with an
apparent molecular mass of 29 kDa. Location of this receptor
on sperm surface is demonstrated both by the ability of the
impermeable conjugate E2-BSA to induce similar calcium
waves, as 17bE2, as well as by the detection of the 29-kDa
protein band in purified sperm membranes by Western anal-
ysis. The possible involvement of such a protein in the bio-
logical effects of 17bE2 is suggested by the inhibition of
17bE2-stimulated [Ca
21]i increase by aH222 antibody, which
probably competes with the steroid for the binding domain
of the membrane receptor. Similarly, Morey et al. (42) showed
that aH222 antibody reverted the biological effects of estro-
gen in vascular smooth muscle cells. A protein with a mo-
FIG. 6. Effect of EGTA on 17bE2- and BSA-E2-induced [Ca
21]i in-
creases. Calcium responses to 17bE2 (10 mmol/L) in calcium-complete
medium (A) and in the absence of extracellular calcium (Ca21-free
medium 1 2 mmol/L EGTA) (B) are shown. Similarly, the calcium
influx induced by BSA-E2 (1 mmol/L) is absent in calcium-depleted
medium (C). The response to the two agonists is restored by subse-
quent addition of 2.5 mmol/L CaCl2. All tracings were obtained in the
same subject. Results are representative of three similar experi-
ments.
FIG. 7. Effect of 17bE2 on basal and P-stimulated AR in human
spermatozoa. Capacitated spermatozoa were treated for 2 h with P (10
mmol/L) or with increasing concentrations of 17bE2 (1 nmol/L, 100
nmol/L, 10 mmol/L), both in the presence or absence of P (10 mmol/L)
and AR, evaluated as described in Materials and Methods. C, Un-
treated control sample. Values represent the mean 6 SEM percentage
of AR for the indicated number of experiments. *, P , 0.05 vs. P; **,
P , 0.005 vs. P; #, P , 0.001 vs. C.
FIG. 8. Effect of aH222 antibody on calcium response to 17bE2 in
fura-2-loaded human spermatozoa. The [Ca21]i increase, induced by
17bE2 (10 mmol/L) (A), was partially reverted after 10-min incubation
of samples with aH222 antibody (1:20) (B). C, Calcium transient,
stimulated by 17bE2 (10 mmol/L), after preincubation with normal rat
serum in the same subject. Results are representative of three similar
experiments.
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lecular mass of about 29 kDa, identified by photoaffinity
labeling with progesterone-11a-hemisuccinate-(2-[125I)iodo-
histamine), and specifically displaced by incubation with
estradiol, has been detected in mouse brain membranes (19,
20) and has been suggested as the putative membrane bind-
ing site for estrogen (20). Moreover, Monje and Boland (37),
using monoclonal antibodies against different domains of
the intracellular estrogen receptor, identified on uterine
membranes a 28- to 32-kDa protein, besides the expected
65-kDa band representing one of the genomic receptors. Such
molecular mass (29 kDa) is quite different from the known
classical a and b estrogen receptors (38, 39). Higher expo-
sures of films in our Western blot analysis of sperm lysates
reveal that aH222 antibody faintly detects two additional
sperm protein bands, the higher of which shows a molecular
weight similar to one of the classical genomic receptors.
Although we have used all the necessary precautions to
minimize eventual protein cleavage, the possibility that the
29-kDa protein band is a proteolytic fragment of the full-
length estrogen receptor cannot be excluded. Also, it possible
that a specific regulatory protein cleavage is involved in
synthesis of the functional estrogen receptor in spermatozoa.
The fact that other bands are seen with aH222 antibody
suggests this possibility. On the other hand, a 66-kDa estro-
gen receptor that comigrates with a similar protein in the
endometrial tissue has been detected, with a different anti-
body in human spermatozoa, by Durkee et al. (15). However,
these authors could not discriminate whether this form rep-
resented the genomic receptor or not. Interestingly, the same
authors detected, by RT-PCR analysis of sperm RNA, two
different amplified nucleotidic bands (15), suggesting the
presence of different messenger RNAs for estrogen receptors
in human spermatozoa, as also described in other cell types
(43, 44). So far, the question of whether classical genomic
estrogen receptors are present in human spermatozoa still
remains open. On the other hand, it is unlikely that the
genomic estrogen receptor, if present, could be functional,
because mature spermatozoa are transcriptionally silent.
Moreover, our experiments clearly show that the 29-kDa
protein band is the only one detected by both ligand and
Western blot analyses, strongly indicating that this protein
represents the membrane receptor for estrogen in human
spermatozoa.
The rapid increase of [Ca21]i and phosphorylation induced
by 17bE2 in human spermatozoa confirms the findings in
other cell types for nongenomic/rapid actions of estrogens
(37, 45–49). As in the case of P (50), both 17bE2- and BSA-
E2-stimulated [Ca
21]i increases in spermatozoa are strictly
dependent on the presence of extracellular calcium. Because
this steroid is present in the follicular fluid (6–8) and in the
male genital tract (12) at concentrations similar to those in-
ducing the biological effects observed in vitro in human sper-
FIG. 9. Identification of sperm 17bE2-
binding proteins by ligand and Western
analysis. Total extracts (30 mg/lane) or
purified membranes (50 mg/lane), from
2- and 24-h capacitated spermatozoa,
were separated on reducing 10% SDS-
PAGE. A, Ligand blot analysis of the
sperm lysates using peroxidase-conju-
gated estradiol (E2-POD, 0.5 mmol/L)
reveals a single binding protein of 29-
kDa molecular mass. After stripping,
the same blot as in A was first probed for
tyrosine-phosphorylated proteins with
peroxidase-conjugated PY20 antibody
(C) and then for estrogen receptor with
aH222 antibody (1:400) (B), followed by
the BM detection system. An exact
alignment of the blots indicates that the
E2-POD-binding protein of 29 kDa (A)
coincides with the band revealed both
by aH222 (B) and PY20 (C) antibodies.
D, Western blot analysis with aH222
(1:400) on purified sperm membranes
reveals the same 29-kDa protein band
as in A and B. E, Higher BM exposure
of a aH222 antibody-stained blot of to-
tal sperm lysates showing other protein
bands besides the 29-kDa one. Molecu-
lar weight markers are indicated to the
left or the right of each blot. Results are
representative of two similar experi-
ments.
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matozoa, it is conceivable that these effects may be physio-
logically relevant. The increase of calcium and tyrosine
phosphorylation of proteins stimulated by 17bE2 in human
spermatozoa is not followed by induction of AR; rather, these
effects interfere with those exerted by P. Indeed, a previous
addition of 17bE2 inhibits, in a dose-dependent manner, the
subsequent calcium and AR responses to P. In particular, the
plateau phase of P calcium response is significantly reduced
after a first priming with very low concentrations of 17bE2.
Because the plateau phase of P-induced [Ca21]i increase has
been associated with induction of AR (50), it is conceivable
that inhibition of P-stimulated AR by 17bE2 is attributable to
inhibition of the plateau phase. Stimulation of tyrosine phos-
phorylation of its own receptor may be involved in the mod-
ulation of receptor binding activity. Indeed, modulation of
the phosphorylation state of the estrogen receptor by the
steroid itself or other substances has been associated with
transactivation of the classical genomic estrogen receptor (40,
41). In particular, tyrosine phosphorylation occurs in the
ligand binding domain of the genomic receptor (52).
The precise mechanism involved in 17bE2 inhibition of
calcium and AR response to P in human spermatozoa is still
unclear. Other groups reported rapid inhibitory effects of
17bE2 on vascular smooth muscle contraction (53–56) and on
neuron hyperpolarization (57). In particular, the rapid inhi-
bitions of coronary artery contraction [either basal (56) or
induced by PG F2a, extracellular potassium (54), and endo-
thelin (55)] seem to be mediated by reduction of cellular
calcium influx via blockage of L-type Ca21 channels (53).
Lagrange et al. (57) reported 17bE2 reduction of m-opioids’
ability to hyperpolarize guinea pig hypotalamic neurons via
G protein-coupled receptors. However, in all these cases, the
inhibitory effects of 17bE2 are never associated with an in-
crease of calcium influx induced by the steroid itself, as in our
experiments. It is possible that the partial stimulation by
17bE2 of the same signal transduction pathways of P inter-
feres with the biological response to the latter, leading to
inhibition of AR. However, the possibility that 17bE2 and P
compete for the same receptors cannot be excluded.
Interestingly, the sperm calcium curve, in response to
17bE2, shows a biphasic behavior, with two components (one
in the nanomolar and the other in the micromolar range),
similar to the calcium curve obtained for P (11). Although this
result may suggest the presence of two different binding sites
for estradiol, we have constantly observed the presence of a
single 29-kDa protein band in ligand blot experiments with
E2-POD. On the other hand, binding of
3H-17bE2 to intact
human spermatozoa revealed the presence of a single bind-
ing site, with a an apparent Kd of 0.6 nmol/L (13), consistent
with the first component of our curve. Similarly, the effect of
17bE2 on P-induced AR and plateau phase of calcium in-
creases was observed at nanomolar concentrations.
Inhibition of rapid responses to 17bE2 by tamoxifen is
controversial (45, 49, 58). Indeed, whereas Lantin-Hermoso
et al. (58) described a complete inhibition by tamoxifen on
estradiol acute stimulation of nitric oxide synthase activity in
artery endothelium, Watters et al. (49) found no effect of
tamoxifen on rapid membrane effects of estrogen in neuro-
blastoma cells. Moreover, Morley et al. (45) showed that
tamoxifen could not affect the rapid estrogen-triggered
[Ca21]i increase in chicken granulosa cells. In our hands, this
FIG. 10. Western blot analysis of total lysates from human myome-
trial cells and human uterus with aH222 antibody. Human uterus
(hUT) and myometrial cell (hM2) lysates were obtained as described
in Materials and Methods, and proteins extracts were separated on
10% reducing SDS-PAGE. Western blot analysis with aH222 anti-
body (1:400) reveals two protein bands in the molecular mass range
of 20–64 kDa. In particular, a 54- to 58-kDa protein band is detected
by aH222, both on myometrial and uterus lysates. A 29-kDa protein
band is observed in myometrial cells. Molecular weight markers are
indicated to the right of the blot.
FIG. 11. Effect of 17bE2 on tyrosine
phosphorylation of p29 kDa protein band
in human spermatozoa. Capacitated
spermatozoa were stimulated for 10 min
with increasing concentrations of 17bE2
(1 nmol/L–10 mmol/L). Protein extracts,
separated on 10% reducing SDS-PAGE,
were first probed with PY20-HRP anti-
body (A), washed, and reprobed with
aH222 antibody (1:400, B). The phos-
phorylated p29 protein band in A exactly
aligns with the 29-kDa protein detected
in B. C, unstimulated control. Molecular
weight markers are indicated to the left of
each blot. Results are representative of
two similar experiments.
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cytosolic estrogen receptor antagonist was ineffective in
counteracting estradiol action on intracellular calcium, fur-
ther suggesting that the estrogen receptor in spermatozoa
differs from the genomic one.
In conclusion, our results demonstrate the presence of a
biologically active sperm receptor for estrogen in human
spermatozoa, suggesting a novel role for estradiol, in the
process of fertilization, as a possible physiological modulator
of P action on spermatozoa. Because levels of estradiol in the
follicular fluid are similar to those inducing the observed
nongenomic effects, the strict cross-talk between sperm
membrane receptors for 17bE2 and P may be important for
an appropriate timing of capacitation and AR in the female
genital tract. Further studies are required to elucidate
whether environmental chemicals with estrogen action
might have similar effects on human sperm and to evaluate
whether the absence of sperm response to P in several cases
of idiopathic male infertility (27, 59) may be attributable to
alteration in the interactions between these two steroids.
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